Rxi Pharmaceuticals Corp (NASDAQ:RXII)

2.75
Delayed Data
As of 3:59pm ET
 -0.01 / -0.36%
Today’s Change
2.51
Today|||52-Week Range
7.70
-50.52%
Year-to-Date
Institutional investors purchased a net $721.8 thousand shares of RXII during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 24.54% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Other institutional24.03%
Mutual fund holders0.51%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

4/09/2018ANSON FUNDS MANAGEMENT LP  Bought 369.1 Thousand shares of Rxi Pharmaceuticals Corp
4/09/2018SABBY CAPITAL LLC  Bought 334.1 Thousand shares of Rxi Pharmaceuticals Corp
3/31/2018SEACREST WEALTH MANAGEMENT LLC  Bought 10.00 shares of Rxi Pharmaceuticals Corp

Top 10 Owners of Rxi Pharmaceuticals Corp

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Sabby Capital LLC14.55%377,6521,216,039+334,084+766.81%
Anson Funds Management LP8.87%377,6521,216,039+369,071+4,301.03%
Geode Capital Management LLC0.63%26,63885,774+23,974+899.92%
Two Sigma Securities LLC0.10%4,22113,592-1,705-28.77%
G1 Execution Services LLC0.08%3,23210,407+3,232--
Citadel Advisors LLC0.07%2,9519,502+1,411+91.62%
Virtu Financial BD LLC0.06%2,5418,182+2,541--
Intellectus Partners LLC0.05%2,0006,440+2,000--
The Vanguard Group, Inc.0.04%1,7975,78600.00%
UBS Securities LLC0.04%1,5344,939+1,534--

Top 10 Mutual Funds Holding Rxi Pharmaceuticals Corp

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Vanguard Extended Market Index Fu...0.43%18,29758,916+16,500+918.20%
Fidelity Extended Market Index Fu...0.06%2,6638,57500.00%
iShares Core S&P Total US Stock M...0.02%4031,29800.00%
Perinvest (Lux) SICAV - Global He...0.00%00-4,892-100.00%